Cited by 33Nausea and vomiting managementCancer survivorship and careCancer Treatment and Pharmacology

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

Abstract

Objective: Risk factors for chemotherapy-induced nausea and vomiting (CINV) include older age, female sex, alcohol consumption, and a history of motion sickness. Although gastrointestinal symptoms are found to be related with sleep and mood in other conditions, little is known about their effects on CINV. Methods: This prospective observational study recruited patients with early-stage breast cancer who had recovered from surgery before receiving a first cycle of anthracycline and cyclophosphamide–based chemotherapy. Candidate factors associated with CINV were assessed before chemotherapy by using the following: the Pittsburgh Sleep Quality Index, the Insomnia Severity Index, the Epworth Sleepiness Scale, and the Hospital Anxiety and Depression Scale. Chemotherapy-induced nausea (CIN) and chemotherapy-induced vomiting (CIV) were defined according to a numeric rating scale (0–10) as follows: ≥3, nausea; ≥1, vomiting. Results: Between February 2012 and May 2014, data were collected from 198 patients. Chemotherapy-induced nausea occurred in 35.4% of patients, and CIV occurred in 31.3%. Chemotherapy-induced nausea was significantly associated with poor sleep quality (odds ratio [OR], 2.48; 95% confidence interval [CI], 1.13–5.46; p = 0.024) and pretreatment nausea (OR, 4.81; 95% CI, 1.84–12.62; p = 0.001). Likewise, CIV was significantly associated with poor sleep quality (OR, 2.64; 95% CI, 1.21–5.78; p = 0.015) and pretreatment nausea (OR, 3.07; 95% CI, 1.23–7.66; p = 0.016). Conclusions: Poor sleep quality increases risk of CINV in patients with breast cancer. Sleep problems should be assessed and considered in the management of CINV.

Overview

Integrity signals

Registry

Crossref · 10.1097/psy.0000000000000372

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Poor sleep quality can worsen symptoms of many serious and chronic conditions, including cancer and multiple sclerosis.

    “Aside from its direct role in ill-health, poor sleep quality can worsen the symptoms of many serious and chronic conditions, including cancer and multiple sclerosis126–128.”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 30

  1. 2012, Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life, Support Care Cancer, 20, 3141, 10.1007/s00520-012-1448-1 · DOI
  2. 2014, Prognostic factors for chemotherapy induced nausea and vomiting, Eur J Pharmacol, 722, 192, 10.1016/j.ejphar.2013.10.015 · DOI
  3. 2014, Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study, J Pain Symptom Manage, 47, 839, 10.1016/j.jpainsymman.2013.06.012 · DOI
  4. 2009, Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide, Ann Pharmacother, 43, 444, 10.1345/aph.1L437 · DOI
  5. 2012, Computational prediction of state anxiety in Asian patients with cancer susceptible to chemotherapy-induced nausea and vomiting, J Clin Psychopharmacol, 32, 207, 10.1097/JCP.0b013e31824888a1 · DOI
  6. 2002, Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients, Support Care Cancer, 10, 139, 10.1007/s00520-001-0321-4 · DOI
  7. 2011, Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study, Support Care Cancer, 19, 1549, 10.1007/s00520-010-0982-y · DOI
  8. 2009, Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population, Neurogastroenterol Motil, 21, 128, 10.1111/j.1365-2982.2008.01181.x · DOI
  9. 2002, The prevalence of nausea in the community: psychological, social and somatic factors, Gen Hosp Psychiatry, 24, 81, 10.1016/S0163-8343(01)00184-0 · DOI
  10. 2015, Is there relationship between social support, psychological distress, mood disorders and emesis gravidarum?, J Obstet Gynaecol, 35, 737, 10.3109/01443615.2015.1004529 · DOI
  11. 2013, Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes, Curr Psychiatry Rep, 15, 404, 10.1007/s11920-013-0404-1 · DOI
  12. 2005, 5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial, Lancet Oncol, 6, 765, 10.1016/S1470-2045(05)70325-9 · DOI
  13. 2006, Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment, J Clin Oncol, 24, 4472, 10.1200/JCO.2006.05.6382 · DOI
  14. 2013, Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting, Support Care Cancer, 21, 2759, 10.1007/s00520-013-1843-2 · DOI
  15. 1998, Psychometric evaluation of the Pittsburgh Sleep Quality Index, J Psychosom Res, 45, 5, 10.1016/S0022-3999(97)00298-5 · DOI · Paper page
  16. 2011, The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response, Sleep, 34, 601, 10.1093/sleep/34.5.601 · DOI · Paper page
  17. 1991, A new method for measuring daytime sleepiness: the Epworth sleepiness scale, Sleep, 14, 540, 10.1093/sleep/14.6.540 · DOI · Paper page
  18. 2002, The validity of the Hospital Anxiety and Depression Scale. An updated literature review, J Psychosom Res, 52, 69, 10.1016/S0022-3999(01)00296-3 · DOI · Paper page
  19. 2006, Sex differences in insomnia: a meta-analysis, Sleep, 29, 85, 10.1093/sleep/29.1.85 · DOI · Paper page
  20. 2001, What are the contributing factors for insomnia in the general population?, J Psychosom Res, 51, 745, 10.1016/S0022-3999(01)00285-9 · DOI
  21. 1996, Control of acute cisplatin-induced emesis over repeat courses of chemotherapy. Italian Group for Antiemetic Research, Oncology, 65
  22. 2013, Management of chemotherapy-induced nausea and vomiting: focus on newer agents and new uses for older agents, Drugs, 73, 249, 10.1007/s40265-013-0019-1 · DOI
  23. 2015, QoL evaluation of olanzapine for chemotherapy-induced nausea and vomiting comparing with 5-HT3 receptor antagonist, Eur J Cancer Care (Engl), 24, 436, 10.1111/ecc.12260 · DOI
  24. 2008, Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression, Psychiatry Clin Neurosci, 62, 75, 10.1111/j.1440-1819.2007.01778.x · DOI
  25. 2004, Vulnerability to stress-related sleep disturbance and hyperarousal, Sleep, 27, 285, 10.1093/sleep/27.2.285 · DOI · Paper page
  26. 2007, Insomnia: pathophysiology and implications for treatment, Sleep Med Rev, 11, 71, 10.1016/j.smrv.2006.06.002 · DOI
  27. 1998, Heart rate variability in insomniacs and matched normal sleepers, Psychosom Med, 60, 610, 10.1097/00006842-199809000-00017 · DOI
  28. 1999, Changes in clinical measures of autonomic nervous system function related to cancer chemotherapy-induced nausea, J Auton Nerv Syst, 78, 57, 10.1016/S0165-1838(99)00053-3 · DOI
  29. 2007, Chemotherapy-induced nausea, vomiting, and fatigue—the role of individual differences related to sensory perception and autonomic reactivity, Psychother Psychosom, 76, 376, 10.1159/000107566 · DOI
  30. 2007, Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool, J Pain Symptom Manage, 34, 148, 10.1016/j.jpainsymman.2006.10.018 · DOI

Cited by

Sorted by citations

Metadata

Authors
Jung, D., Lee, K.-M., Kim, W.-H., Lee, J.-Y., Kim, T.-Y., Im, S.-A., Lee, K.-H., Spiegel, D., & Hahm, B.-J.
Affiliations
Seoul National University (KR)
Corresponding author
Hahm, Bong-Jin
Venue
Psychosomatic Medicine
Published
2016-10
Volume
78
Issue
8
Pages
959-965
ISSN
  • 0033-3174 (ISSN-L)
  • 1534-7796
OpenAlex
W2464293807
Cited by
33
References
1
Citations by year
2026: 6 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 1
FWCI
2.58
Type
journal article
Language
en
Open access
closed
Locations
  • Psychosomatic Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
  • Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Nausea and vomiting management
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
Keywords
chemotherapy-induced nausea and vomiting, sleep quality, breast cancer, insomnia, anxiety, depression, risk factors, sleepiness
MeSH terms
Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Female, Humans, Longitudinal Studies, Middle Aged, Nausea, Sleep Wake Disorders, Vomiting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review